Ligands of the peroxisome proliferator-activated receptor Î³ inhibit hepatoce llular carcinoma cell proliferation.

Jin, Zhe; Jia, Baoxing; Fu, Yu; Tan, Ludong; Chen, Qingmin; Jiang, Peiqiang; Liu, Yahui.

Afiliación

Jin Z; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Jia B; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Fu Y; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Tan L; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Chen Q; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Jiang P; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Liu Y; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.

Oncol Lett ; 14(4): 4767-4771, 2017 Oct.

Article en En | MEDLINE | ID: mdl-28943966